Terminated NA INTERVENTIONAL 2-arm NCT00159211

Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

Evolution of Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin, in Association With Metformin or Sulfonylurea.

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Type 2 Diabetes

Interventions UMULINE NPH pioglitazone

Updated 5 times since 2017 Last updated: Nov 6, 2007 Started: May 31, 2005 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inclusion was finished

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

Other Type 2 Diabetes trials with similar outcome

Browse all Type 2 Diabetes trials

A NA clinical study on Type 2 Diabetes, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
Laboratoires Takeda

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France